MedTrace Logo

Precision Antimicrobial STewardship for Clostridioides DIfficile Prevention

NCT05508607 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13319

Last updated 2022-08-19

No results posted yet for this study

Summary

To decrease CDI incidence by implementing an electronic health record-integrated CDI-risk classification tool for Clostridioides difficile infection (CDI) to focus a bundle of antimicrobial stewardship (AMS) CDI prevention recommendations on high-risk patients.

Conditions

Interventions

OTHER

CDI-risk Classification Tool

This tool will focus a bundle of antimicrobial stewardship (AMS) CDI prevention recommendations on high-risk patients.

Sponsors & Collaborators

  • Intermountain Health Care, Inc.

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-01
Primary Completion
2022-06-30
Completion
2022-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05508607 on ClinicalTrials.gov